These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 39268898)
1. Overcoming challenges of managing chronic obstructive pulmonary disease in low- and middle-income countries. Alupo P; Baluku J; Bongomin F; Siddharthan T; Katagira W; Ddungu A; Hurst JR; van Boven JFM; Worodria W; Kirenga BJ Expert Rev Respir Med; 2024 Nov; 18(11):873-882. PubMed ID: 39268898 [TBL] [Abstract][Full Text] [Related]
2. Mapping the Common Barriers to Optimal COPD Care in High and Middle-Income Countries: Qualitative Perspectives from Clinicians. Shahaj O; Meiwald A; Puri Sudhir K; Gara-Adams R; Wark P; Cazaux A; Rios AE; Avdeev SN; Adams EJ Int J Chron Obstruct Pulmon Dis; 2024; 19():1207-1223. PubMed ID: 38831892 [TBL] [Abstract][Full Text] [Related]
3. Challenges in the Implementation of Chronic Obstructive Pulmonary Disease Guidelines in Low- and Middle-Income Countries: An Official American Thoracic Society Workshop Report. Hurst JR; Buist AS; Gaga M; Gianella GE; Kirenga B; Khoo EM; Mendes RG; Mohan A; Mortimer K; Rylance S; Siddharthan T; Singh SJ; van Boven JFM; Williams S; Zhang J; Checkley W Ann Am Thorac Soc; 2021 Aug; 18(8):1269-1277. PubMed ID: 34328399 [TBL] [Abstract][Full Text] [Related]
4. Unmet Diagnostic and Therapeutic Opportunities for Chronic Obstructive Pulmonary Disease in Low- and Middle-Income Countries. Florman KEH; Siddharthan T; Pollard SL; Alupo P; Barber JA; Chandyo RK; Flores-Flores O; Kirenga B; Mendes RG; Miranda JJ; Mohan S; Ricciardi F; Rykiel NA; Sharma AK; Wosu AC; Checkley W; Hurst JR; Am J Respir Crit Care Med; 2023 Aug; 208(4):442-450. PubMed ID: 37369142 [No Abstract] [Full Text] [Related]
5. Strategies for the prevention, diagnosis and treatment of COPD in low- and middle- income countries: the importance of primary care. Rossaki FM; Hurst JR; van Gemert F; Kirenga BJ; Williams S; Khoo EM; Tsiligianni I; Tabyshova A; van Boven JF Expert Rev Respir Med; 2021 Dec; 15(12):1563-1577. PubMed ID: 34595990 [TBL] [Abstract][Full Text] [Related]
6. Challenges to Implementation of Community Health Worker-Led Chronic Obstructive Pulmonary Disease (COPD) Screening and Referral in Rural Uganda: A Qualitative Study using the Implementation Outcomes Framework. Ingenhoff R; Robertson N; Munana R; Bodnar BE; Weswa I; Sekitoleko I; Gaal J; Kirenga BJ; Kalyesubula R; Knauf F; Siddharthan T Int J Chron Obstruct Pulmon Dis; 2023; 18():2769-2783. PubMed ID: 38046984 [TBL] [Abstract][Full Text] [Related]
7. Awareness of COPD in low-and middle-income countries and implications for treatment. Ghorpade D; Salvi S Expert Rev Respir Med; 2024 Sep; 18(9):721-733. PubMed ID: 39246242 [TBL] [Abstract][Full Text] [Related]
8. The complications of treating chronic obstructive pulmonary disease in low income countries of sub-Saharan Africa. van Gemert FA; Kirenga BJ; Gebremariam TH; Nyale G; de Jong C; van der Molen T Expert Rev Respir Med; 2018 Mar; 12(3):227-237. PubMed ID: 29298106 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness-implementation of COPD case finding and self-management action plans in low- and middle-income countries: global excellence in COPD outcomes (GECo) study protocol. Siddharthan T; Pollard SL; Quaderi SA; Mirelman AJ; Cárdenas MK; Kirenga B; Rykiel NA; Miranda JJ; Shrestha L; Chandyo RK; Cattamanchi A; Michie S; Barber J; Checkley W; Hurst JR; Trials; 2018 Oct; 19(1):571. PubMed ID: 30340648 [TBL] [Abstract][Full Text] [Related]
10. The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review. Stolbrink M; Thomson H; Hadfield RM; Ozoh OB; Nantanda R; Jayasooriya S; Allwood B; Halpin DMG; Salvi S; de Oca MM; Mortimer K; Rylance S Lancet Glob Health; 2022 Oct; 10(10):e1423-e1442. PubMed ID: 36113528 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Influenza Vaccination for Individuals with Chronic Obstructive Pulmonary Disease (COPD) in Low- and Middle-Income Countries. Lall D; Cason E; Pasquel FJ; Ali MK; Narayan KM COPD; 2016; 13(1):93-9. PubMed ID: 26418892 [TBL] [Abstract][Full Text] [Related]
12. Gaps in COPD Guidelines of Low- and Middle-Income Countries: A Systematic Scoping Review. Tabyshova A; Hurst JR; Soriano JB; Checkley W; Wan-Chun Huang E; Trofor AC; Flores-Flores O; Alupo P; Gianella G; Ferdous T; Meharg D; Alison J; Correia de Sousa J; Postma MJ; Chavannes NH; van Boven JFM Chest; 2021 Feb; 159(2):575-584. PubMed ID: 33038390 [TBL] [Abstract][Full Text] [Related]
13. Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade. Adeloye D; Agarwal D; Barnes PJ; Bonay M; van Boven JF; Bryant J; Caramori G; Dockrell D; D'Urzo A; Ekström M; Erhabor G; Esteban C; Greene CM; Hurst J; Juvekar S; Khoo EM; Ko FW; Lipworth B; López-Campos JL; Maddocks M; Mannino DM; Martinez FJ; Martinez-Garcia MA; McNamara RJ; Miravitlles M; Pinnock H; Pooler A; Quint JK; Schwarz P; Slavich GM; Song P; Tai A; Watz H; Wedzicha JA; Williams MC; Campbell H; Sheikh A; Rudan I J Glob Health; 2021; 11():15003. PubMed ID: 34737870 [TBL] [Abstract][Full Text] [Related]
14. Essential medicines for COPD and asthma in low and middle-income countries. Bazargani YT; de Boer A; Leufkens HG; Mantel-Teeuwisse AK Thorax; 2014 Dec; 69(12):1149-51. PubMed ID: 24590803 [TBL] [Abstract][Full Text] [Related]
15. Recommendations for COPD management in Central and Eastern Europe. Valipour A; Aisanov Z; Avdeev S; Koblizek V; Kocan I; Kopitovic I; Lupkovics G; Man M; Bukovskis M; Tudoric N; Vukoja M; Naumnik W; Yanev N Expert Rev Respir Med; 2022 Feb; 16(2):221-234. PubMed ID: 35001780 [TBL] [Abstract][Full Text] [Related]
16. The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries. Halpin DMG; Celli BR; Criner GJ; Frith P; López Varela MV; Salvi S; Vogelmeier CF; Chen R; Mortimer K; Montes de Oca M; Aisanov Z; Obaseki D; Decker R; Agusti A Int J Tuberc Lung Dis; 2019 Nov; 23(11):1131-1141. PubMed ID: 31718748 [TBL] [Abstract][Full Text] [Related]
17. Amid COVID-19 pandemic: Challenges with access to care for COPD patients. Elbeddini A; Tayefehchamani Y Res Social Adm Pharm; 2021 Jan; 17(1):1934-1937. PubMed ID: 32513515 [TBL] [Abstract][Full Text] [Related]
18. Improving access to health care for people with severe chronic obstructive pulmonary disease (COPD) in Southern New Zealand: qualitative study of the views of health professional stakeholders and patients. Stokes T; Tumilty E; Latu ATF; Doolan-Noble F; Baxter J; McAuley K; Hannah D; Donlevy S; Dummer J BMJ Open; 2019 Nov; 9(11):e033524. PubMed ID: 31767598 [TBL] [Abstract][Full Text] [Related]
19. Development and Validity Assessment of a Chronic Obstructive Pulmonary Disease Knowledge Questionnaire in Low- and Middle-Income Countries. Robertson NM; Siddharthan T; Pollard SL; Alupo P; Flores-Flores O; Rykiel NA; Romani ED; Ascencio-Días I; Kirenga B; Checkley W; Hurst JR; Quaderi S; Ann Am Thorac Soc; 2021 Aug; 18(8):1298-1305. PubMed ID: 33476252 [No Abstract] [Full Text] [Related]
20. Management of NCD in low- and middle-income countries. Checkley W; Ghannem H; Irazola V; Kimaiyo S; Levitt NS; Miranda JJ; Niessen L; Prabhakaran D; Rabadán-Diehl C; Ramirez-Zea M; Rubinstein A; Sigamani A; Smith R; Tandon N; Wu Y; Xavier D; Yan LL; Glob Heart; 2014 Dec; 9(4):431-43. PubMed ID: 25592798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]